ACBD3 and breast carcinoma: Biomax arrays with over 300 tissues cores were chosen to compare cancerous tissue with normal adjacent tissue, in addition to a comparison of expression between different breast cancer subgroups, with an emphasis on ACBD3 expression in receptor-positive versus receptor-negative breast cancers.